3D bioprinting technologies have to become more accessible in order for the greater scientific community to benefit from its merits. Allevi’s Commercial Director, Dr. Hanchih Wu, shares her personal experience on how to move the needle in the lab and bring in novel techniques into your workflow.
3D bioprinting technology continues to evolve and shape the way modern medicine approach the therapeutic research process. We present a short digest on what bioprinting experts sees as important milestones and movements in the 3D bioprinting world.
What if we could decrease pharmaceutical development’s dependence on animal studies while increasing clinical trial success and developing more safe and effective drugs? A bill recently passed unanimously by the United States Senate is at the heart of this discussion and can pave the way for the adoption of technologies that enable overcoming this challenging goal.
With recent advances in 3D bioprinting technology we welcome the development of new biomaterials and bioinks. Yu and colleagues, a group of researchers based in Taiwan, presents a potential new photocrosslinkable bioink based on keratin and chitosan that supports stem cell and spheroid loading and culture, paving ways for cell-laden biofabricated hydrogels development.